Location: San Diego, CA
CIK: 0002018299 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $1.328B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TNGX | TANGO THERAPEUTICS INC | 10,876,219 | $340M | 25.6% | — | — | COM | 87583X109 |
| RVMD | REVOLUTION MEDICINES INC | 500,000 | $93.64M | 7.1% | — | — | COM | 76155X100 |
| ABVX | ABIVAX SA | 605,000 | $80.62M | 6.1% | — | — | SPONSORED ADS | 00370M103 |
| QURE | UNIQURE NV | 1,503,300 | $69.24M | 5.2% | — | — | SHS | N90064101 |
| KOD | KODIAK SCIENCES INC | 1,477,600 | $57.57M | 4.3% | — | — | COM | 50015M109 |
| KYMR | KYMERA THERAPEUTICS INC | 429,100 | $49.2M | 3.7% | — | — | COM | 501575104 |
| DFTX | DEFINIUM THERAPEUTICS INC | 998,500 | $46.97M | 3.5% | — | — | COM SHS | 24477V105 |
| REPL | REPLIMUNE GROUP INC | 3,983,000 | $44.09M | 3.3% | — | — | COM | 76029N106 |
| CELC | CELCUITY INC | 416,530 | $43.58M | 3.3% | — | — | COM | 15102K100 |
| QTTB | Q32 BIO INC | 3,149,310 | $40.12M | 3.0% | — | — | COM | 746964105 |
| CAPR | CAPRICOR THERAPEUTICS INC | 1,395,156 | $33.6M | 2.5% | — | — | COM NEW | 14070B309 |
| PGEN | PRECIGEN INC | 5,150,000 | $29.36M | 2.2% | — | — | COM | 74017N105 |
| CORT | CORCEPT THERAPEUTICS INC | 335,500 | $29.17M | 2.2% | — | — | COM | 218352102 |
| SRZN | Surrozen Inc. | 1,105,683 | $26.96M | 2.0% | — | — | COM NEW | 86889P208 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 170,000 | $20.84M | 1.6% | — | — | COM | 74366E102 |
| VIR | VIR BIOTECHNOLOGY INC | 1,866,000 | $19.01M | 1.4% | — | — | COM | 92764N102 |
| PCVX | VAXCYTE INC | 325,000 | $18.89M | 1.4% | — | — | COM | 92243G108 |
| URGN | UROGEN PHARMA LTD | 500,000 | $18.4M | 1.4% | — | — | COM | M96088105 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,100,000 | $16.43M | 1.2% | — | — | COM | 221015100 |
| PTCT | PTC THERAPEUTICS INC | 200,000 | $16.31M | 1.2% | — | — | COM | 69366J200 |
| PRAX | PRAXIS PRECISION MEDICINES I | 46,457 | $15.55M | 1.2% | — | — | COM NEW | 74006W207 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 800,000 | $14.37M | 1.1% | — | — | COM | 03237H101 |
| OCUL | OCULAR THERAPEUTIX INC | 1,300,000 | $12.77M | 1.0% | — | — | COM | 67576A100 |
| IRD | OPUS GENETICS INC | 2,815,000 | $11.57M | 0.9% | — | — | COM | 67577R102 |
| PALI | PALISADE BIO INC | 4,799,875 | $10.03M | 0.8% | — | — | COM | 696389402 |
| APGE | APOGEE THERAPEUTICS INC | 70,000 | $9.291M | 0.7% | — | — | COM | 03770N101 |
| SYRE | SPYRE THERAPEUTICS INC | 100,000 | $8.878M | 0.7% | — | — | COM NEW | 00773J202 |
| COGT | COGENT BIOSCIENCES INC | 225,000 | $8.707M | 0.7% | — | — | COM | 19240Q201 |
| CYTK | CYTOKINETICS INC | 100,000 | $8.519M | 0.6% | — | — | COM NEW | 23282W605 |
| RLAY | RELAY THERAPEUTICS INC | 450,000 | $8.419M | 0.6% | — | — | COM | 75943R102 |
| — | CRESCENT BIOPHARMA INC. | 453,686 | $8.166M | 0.6% | — | — | COM | 38000Q201 |
| CTNM | CONTINEUM THERAPEUTICS INC | 494,000 | $8.097M | 0.6% | — | — | CL A | 21217B100 |
| KZIA | KAZIA THERAPEUTICS LTD | 560,000 | $7.885M | 0.6% | — | — | SPONSORED ADS | 48669G303 |
| STTK | SHATTUCK LABS INC | 1,000,000 | $6.94M | 0.5% | — | — | COM | 82024L103 |
| AVTX | AVALO THERAPEUTICS INC | 375,000 | $6.93M | 0.5% | — | — | COM NEW | 05338F306 |
| FBRX | FORTE BIOSCIENCES INC | 274,500 | $5.833M | 0.4% | — | — | COM NEW | 34962G208 |
| RLMD | RELMADA THERAPEUTICS INC | 842,106 | $5.827M | 0.4% | — | — | COM | 75955J402 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 275,000 | $5.354M | 0.4% | — | — | CLASS A ORD | 61559X104 |
| ZURA | ZURA BIO LTD | 900,000 | $5.31M | 0.4% | — | — | CLASS A ORD SHS | G9TY5A101 |
| HELP | CYBIN INC | 790,000 | $5.222M | 0.4% | — | — | COM NEW | 23256X407 |
| ODTX | ODYSSEY THERAPEUTICS INC | 275,000 | $5.145M | 0.4% | — | — | COMMON STOCK | 67613T104 |
| IMTX | IMMATICS N.V | 475,000 | $4.812M | 0.4% | — | — | SHS | N44445109 |
| SNSE | FAETH THERAPEUTICS inc | 180,505 | $4.513M | 0.3% | — | — | COM NEW | 81728A207 |
| GPCR | STRUCTURE THERAPEUTICS INC | 75,000 | $4.025M | 0.3% | — | — | SPONSORED ADS | 86366E106 |
| ORIC | ORIC PHARMACEUTICALS INC | 350,000 | $3.791M | 0.3% | — | — | COM | 68622P109 |
| ANTX | AN2 THERAPEUTICS INC | 749,035 | $3.625M | 0.3% | — | — | COM | 037326105 |
| NMRA | NEUMORA THERAPEUTICS INC. | 2,000,000 | $3.4M | 0.3% | — | — | COM | 640979100 |
| INO | INOVIO PHARMACEUTICALS INC | 2,844,994 | $3.129M | 0.2% | — | — | COM SHS | 45773H409 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,500,000 | $3.12M | 0.2% | — | — | COM | 019770106 |
| SLDB | SOLID BIOSCIENCES INC | 300,000 | $2.997M | 0.2% | — | — | COM NEW | 83422E204 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 302,536 | $2.956M | 0.2% | — | — | COM NEW | 48576U205 |
| CLNN | CLENE INC | 477,515 | $2.939M | 0.2% | — | — | COM NEW | 185634201 |
| SRPT | SAREPTA THERAPEUTICS INC | 150,000 | $2.696M | 0.2% | — | — | COM | 803607100 |
| MPLT | MAPLIGHT THERAPEUTICS INC | 75,000 | $2.688M | 0.2% | — | — | COM | 56565P103 |
| NRIX | NURIX THERAPEUTICS INC | 100,000 | $2.426M | 0.2% | — | — | COM | 67080M103 |
| LBRX | LB PHARMACEUTICALS INC | 70,000 | $2.272M | 0.2% | — | — | COM SHS | 50180M108 |
| EDSA | EDESA BIOTECH INC | 205,000 | $1.667M | 0.1% | — | — | COM NEW | 27966L306 |
| IVVD | INVIVYD INC | 1,500,000 | $1.309M | 0.1% | — | — | COM | 00534A102 |
| UPB | UPSTREAM BIO INC | 150,000 | $1.038M | 0.1% | — | — | COM | 91678A107 |
| MIST | MILESTONE PHARMACEUTICALS IN | 666,666 | $893K | 0.1% | — | — | COM | 59935V107 |
| PEPG | PEPGEN INC | 272,892 | $491K | 0.0% | — | — | COM | 713317105 |
| RGNX | REGENXBIO INC | 15,000 | $180K | 0.0% | — | — | COM | 75901B107 |
| SRZNW | SURROZEN INC | 66,666 | $1,067 | 0.0% | — | — | *W EXP 08/01/203 | 86889P117 |